Ventus Therapeutics
Ventus Therapeutics is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, with research operations in Montreal, Canada. Ventus uses its proprietary, machine-learning-enabled computational chemistry and structural biology platform, ReSOLVE, together with deep protein-science expertise, to design differentiated small-molecule therapeutics targeting the innate immune system (including cGAS and NLRP3 inhibitors) for autoimmune and inflammatory diseases, neurological disorders, and cancer. It was surfaced as an a16z portfolio company and added to the API Evangelist network. Enrichment confirmed Ventus operates a corporate/investor website only and publishes no public developer API, SDK, OpenAPI, MCP server, or /.well-known discovery surface.
Ventus Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Therapeutics.
Ventus Therapeutics’ developer surface includes engineering blog, support, and 7 more developer resources.
Kin Score
Resources
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 2
Properties that don't map to a standard resource type